{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "456482b2-214e-4d65-9fa8-9350ec644a09",
   "metadata": {},
   "source": [
    "# COVID-19"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6ed48fcb-bdde-4e03-ba0a-5c62f4435dd1",
   "metadata": {
    "tags": []
   },
   "source": [
    ":::{note}\n",
    "- FDA Covid-19 Info https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-and-emerging-threats/coronavirus-disease-2019-covid-19\n",
    "- FDA list of Covid-19 related guidance documents https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-related-guidance-documents-industry-fda-staff-and-other-stakeholders\n",
    ":::"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "39f4091b-5b9e-4416-b043-1647a5062090",
   "metadata": {
    "tags": [
     "hide-input"
    ]
   },
   "outputs": [
    {
     "data": {
      "text/markdown": [
       "There are 71 documents with topic or summary including 'COVID' and related to CDER. Below is a list of these topics."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "execution_count": 1,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "from IPython.display import Markdown as md\n",
    "pd.set_option('display.max_rows', 200, 'display.max_colwidth', None)\n",
    "df=pd.read_csv(\"../suppfiles/lstcurrent.csv\")\n",
    "\n",
    "#lst2=df.drop(['Unnamed: 0'], axis=1).set_index(['Summary','Topic','FDA Organization']).filter(regex='COVID',axis=0).filter(regex='\\(CDER\\)',axis=0).reset_index()\n",
    "lst2=df.drop(['Unnamed: 0'], axis=1).set_index(['Summary','Topic','FDA Organization']).filter(regex='COVID',axis=0).reset_index()\n",
    "\n",
    "md(\"There are \"+str(len(lst2))+\" documents with topic or summary including 'COVID' and related to CDER. Below is a list of these topics.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "ec419bc0-4309-4e96-ba63-d15a0412bd73",
   "metadata": {
    "tags": [
     "hide-input"
    ]
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th>Summary</th>\n",
       "      <th>Topic</th>\n",
       "      <th>Guidance Status</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Issue Date0</th>\n",
       "      <th>FDA Organization</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2022-05-04</th>\n",
       "      <th>(CBER) (CDRH)</th>\n",
       "      <td>Supplements for Approved Premarket Approval (PMA) or Humanitarian Device Exemption (HDE) Submissions During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised):  Guidance for Industry and Food and Drug Administration Staff</td>\n",
       "      <td>HUD/HDE, Premarket Approval (PMA)</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2022-03-31</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>Emergency Use Authorization for Vaccines to Prevent COVID-19:  Guidance for Industry</td>\n",
       "      <td>Vaccines</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2022-02-08</th>\n",
       "      <th>(CDER)</th>\n",
       "      <td>COVID-19 Public Health Emergency Policy on COVID-19-Related Sanitation Tunnels:  Guidance for Industry and Investigators</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2022-02-04</th>\n",
       "      <th>(OCE) (CBER) (CDER)</th>\n",
       "      <td>Nonclinical Considerations for Mitigating Nonhuman Primate Supply Constraints Arising from the COVID-19 Pandemic:  Guidance for Industry</td>\n",
       "      <td>Pharmacology/Toxicology</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2022-01-07</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>Investigational COVID-19 Convalescent Plasma:  Guidance for Industry</td>\n",
       "      <td>Blood Products</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"2\" valign=\"top\">2021-12-23</th>\n",
       "      <th>(CDRH)</th>\n",
       "      <td>Transition Plan for Medical Devices Issued Emergency Use Authorizations (EUAs) During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency: Draft Guidance for Industry and Food and Drug Administration Staff</td>\n",
       "      <td>Premarket, Postmarket,</td>\n",
       "      <td>Draft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>(CDRH)</th>\n",
       "      <td>Transition Plan for Medical Devices That Fall Within Enforcement Policies Issued During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency: Draft Guidance for Industry and Food and Drug Administration Staff</td>\n",
       "      <td>Premarket, Postmarket,</td>\n",
       "      <td>Draft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2021-12-10</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>Policy for Certain REMS Requirements During the Tocilizumab Shortage Related to the COVID-19 Public Health Emergency:  Guidance for Industry and Health Care Professionals</td>\n",
       "      <td>Gene Therapy</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2021-11-15</th>\n",
       "      <th>(CDRH)</th>\n",
       "      <td>Enforcement Policy for Viral Transport Media During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised):  Guidance for Commercial Manufacturers, Clinical Laboratories, and Food and Drug Administration Staff</td>\n",
       "      <td>Premarket, 510(k)</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2021-09-15</th>\n",
       "      <th>(CDRH)</th>\n",
       "      <td>Enforcement Policy for Face Masks, Barrier Face Coverings, Face Shields, Surgical Masks, and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Revised):  Guidance for Industry and Food and Drug Administration Staff</td>\n",
       "      <td>Premarket, Labeling</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2021-09-08</th>\n",
       "      <th>(CDER)</th>\n",
       "      <td>Development of Abbreviated New  Drug Applications During the  COVID-19 Pandemic – Questions and  Answers Guidance for Industry:  COVID 19 Guidance</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2021-08-30</th>\n",
       "      <th>(CBER) (CDRH) (CDER) Office of the Commissioner,Office of Clinical Policy and Programs,Office of Clinical Policy,Office of Good Clinical Practice</th>\n",
       "      <td>FDA Guidance on Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency:  Guidance for Industry, Investigators, and Institutional Review Boards</td>\n",
       "      <td>Emergencies, Clinical - Medical</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"2\" valign=\"top\">2021-05-17</th>\n",
       "      <th>(ORA) (CBER) (CDER)</th>\n",
       "      <td>Manufacturing, Supply Chain, and Drug and Biological Product Inspections During COVID-19 Public Health Emergency Questions and Answers:  Guidance for Industry</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>(OCE) (CBER) (CDER)</th>\n",
       "      <td>COVID-19: Master Protocols Evaluating Drugs and Biological Products for Treatment or Prevention:  Guidance for Industry</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2021-04-14</th>\n",
       "      <th>(CVM) (CBER) (CDER)</th>\n",
       "      <td>Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities During the COVID-19 Public Health Emergency  Guidance for Industry:  Guidance for Industry</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2021-03-04</th>\n",
       "      <th>(CBER) (CDER)</th>\n",
       "      <td>COVID-19 Container Closure System and Component Changes: Glass Vials and Stoppers  Guidance for Industry:  Guidance for Industry</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"2\" valign=\"top\">2021-02-22</th>\n",
       "      <th>(CDRH)</th>\n",
       "      <td>Policy for Evaluating Impact of Viral Mutations on COVID-19 Tests:  Guidance for Test Developers and Food and Drug Administration Staff</td>\n",
       "      <td>Premarket, IVDs (In Vitro Diagnostic Devices)</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>(CDER)</th>\n",
       "      <td>Development of Monoclonal Antibody Products Targeting SARS-CoV-2, Including Addressing the Impact of Emerging Variants, During the COVID 19 Public Health Emergency</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2021-01-28</th>\n",
       "      <th>(CDRH)</th>\n",
       "      <td>Coagulation Systems for Measurement of Viscoelastic Properties: Enforcement Policy During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised):  Guidance for Industry and Food and Drug Administration Staff</td>\n",
       "      <td>Premarket, Hematology &amp; Pathology , Immunology &amp; Microbiology</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"2\" valign=\"top\">2021-01-19</th>\n",
       "      <th>(CDER) (CBER) (CVM)</th>\n",
       "      <td>Policy for Testing of Alcohol (Ethanol) and Isopropyl Alcohol for Methanol, Including During the Public Health Emergency  (COVID-19):  Guidance for Industry</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>(CBER)</th>\n",
       "      <td>Manufacturing Considerations for Licensed and Investigational Cellular and Gene Therapy Products During COVID-19 Public Health Emergency:  Guidance for Industry</td>\n",
       "      <td>Gene Therapy</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2021-01-15</th>\n",
       "      <th>(CDER)</th>\n",
       "      <td>Protecting Participants in Bioequivalence Studies for Abbreviated New Drug Applications During the COVID-19 Public Health Emergency</td>\n",
       "      <td>Bioequivalence</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2021-01-13</th>\n",
       "      <th>(CDER)</th>\n",
       "      <td>COVID-19: Potency Assay Considerations for Monoclonal Antibodies and Other Therapeutic Proteins Targeting SARS-CoV-2 Infectivity</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-12-21</th>\n",
       "      <th>(CBER) (CDER)</th>\n",
       "      <td>Review Timelines for Applicant Responses to Complete Response Letters When a Facility Assessment Is Needed During the COVID-19 Public Health Emergency Guidance for Industry:  Guidance for Industry</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-12-04</th>\n",
       "      <th>(CDRH)</th>\n",
       "      <td>Enforcement Policy for the Quality Standards of the Mammography Quality Standards Act During the COVID-19 Public Health Emergency:  Guidance for Mammography Facilities, State MQSA Contract Partners, FDA-Approved MQSA Accreditation Bodies, and Food and Drug Administration Staff</td>\n",
       "      <td>Radiological Health, Radiology</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-11-25</th>\n",
       "      <th>(CDRH) ,Office of Strategic Partnerships and Technology Innovation</th>\n",
       "      <td>Notifying CDRH of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&amp;C Act During the COVID-19 Public Health Emergency (Revised):  Guidance for Industry and Food and Drug Administration Staff</td>\n",
       "      <td>Postmarket,</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-10-28</th>\n",
       "      <th>(CDRH)</th>\n",
       "      <td>Enforcement Policy for Non-Invasive Remote Monitoring Devices Used to Support Patient Monitoring During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised):  Guidance for Industry and Food and Drug Administration Staff</td>\n",
       "      <td>Premarket, 510(k), Labeling</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-10-13</th>\n",
       "      <th>(CDRH) ,Office of Product Evaluation and Quality</th>\n",
       "      <td>Enforcement Policy for Modifications to FDA Cleared Molecular Influenza and RSV Tests During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff</td>\n",
       "      <td>IVDs (In Vitro Diagnostic Devices)</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-09-14</th>\n",
       "      <th>(CBER) (CDER)</th>\n",
       "      <td>Assessing COVID-19-Related Symptoms in Outpatient Adult and Adolescent Subjects in Clinical Trials of Drugs and Biological Products for COVID-19 Prevention or Treatment :  Guidance for Industry</td>\n",
       "      <td>Clinical - Medical</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-09-10</th>\n",
       "      <th>(CVM) (CBER) (CDER)</th>\n",
       "      <td>Resuming Normal Drug and Biologics Manufacturing Operations During the COVID-19 Public Health Emergency:  Guidance for Industry</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-06-30</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>Development and Licensure of Vaccines to Prevent COVID-19:  Guidance for Industry</td>\n",
       "      <td>Vaccines</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-06-19</th>\n",
       "      <th>(CVM) (CBER) (CDER)</th>\n",
       "      <td>Good Manufacturing Practice Considerations for Responding to COVID-19 Infection in Employees in Drug and Biological Products Manufacturing:  Guidance for Industry</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-06-16</th>\n",
       "      <th>(CDER) (CBER) (CDRH) (CVM)</th>\n",
       "      <td>Statistical Considerations for Clinical Trials During the COVID-19 Public Health Emergency Guidance for Industry:  Guidance for Industry</td>\n",
       "      <td>Clinical Trials,</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-06-08</th>\n",
       "      <th>(CDER)</th>\n",
       "      <td>Temporary Policy on Prescription Drug Marketing Act Requirements for Distribution of Drug Samples During the COVID-19 Public Health Emergency:  Guidance for Industry</td>\n",
       "      <td>Clinical - Medical, Prescription Drugs</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-06-04</th>\n",
       "      <th>(CFSAN) (CVM)</th>\n",
       "      <td>Temporary Policy Regarding Preventive Controls and FSVP Food Supplier Verification Onsite Audit Requirements During the COVID-19 Public Health Emergency:  Guidance for Industry</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-06-02</th>\n",
       "      <th>(CDER)</th>\n",
       "      <td>Institutional Review Board (IRB) Review of Individual Patient Expanded Access Requests for Investigational Drugs and Biological Products During the COVID-19 Public Health Emergency   Guidance for IRBs and Clinical Investigators:   Guidance for IRBs and Clinical Investigators</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-05-27</th>\n",
       "      <th>(CFSAN)</th>\n",
       "      <td>Reporting a Temporary Closure or Significantly Reduced Production by a Human Food Establishment and Requesting FDA Assistance During the COVID-19 Public Health Emergency:  Guidance for Industry</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-05-26</th>\n",
       "      <th>(CDER) (CBER)</th>\n",
       "      <td>Effects of the COVID-19 Public Health Emergency on Formal Meetings and User Fee Applications — Questions and Answers</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"2\" valign=\"top\">2020-05-22</th>\n",
       "      <th>(CFSAN) ,Office of Nutrition and Food Labeling</th>\n",
       "      <td>Temporary Policy Regarding Certain Food Labeling Requirements During the COVID-19 Public Health Emergency: Minor Formulation Changes and Vending Machines:  Guidance for Industry</td>\n",
       "      <td>Labeling</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>(CFSAN)</th>\n",
       "      <td>Temporary Policy During the COVID-19 Public Health Emergency Regarding the Qualified Exemption from the Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption:  Guidance for Industry</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-05-12</th>\n",
       "      <th>(CVM) (CFSAN)</th>\n",
       "      <td>Returning Refrigerated Transport Vehicles and Refrigerated Storage Units to Food Uses After Using Them to Preserve Human Remains During the COVID-19 Pandemic:  Guidance for Industry</td>\n",
       "      <td>Transportation</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"2\" valign=\"top\">2020-05-11</th>\n",
       "      <th>(CDER) (CBER)</th>\n",
       "      <td>COVID-19 Public Health Emergency: General Considerations for Pre-IND  Meeting Requests for COVID-19 Related Drugs and Biological Products :  Guidance for Industry and Investigators</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>(CBER) (CDER)</th>\n",
       "      <td>COVID-19: Developing Drugs and Biological Products for Treatment or Prevention:  Guidance for Industry</td>\n",
       "      <td>Clinical - Medical</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-05-07</th>\n",
       "      <th>(CVM)</th>\n",
       "      <td>CVM GFI #271 Reporting and Mitigating Animal Drug Shortages during the COVID-19 Public Health Emergency</td>\n",
       "      <td>Postmarket, Animal Drugs, Chemistry, Manufacturing, and Controls (CMC)</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-04-30</th>\n",
       "      <th>(CDER) (CBER)</th>\n",
       "      <td>Exemption and Exclusion from Certain Requirements of the Drug Supply Chain Security Act During the COVID-19 Public Health Emergency:  Guidance for Industry</td>\n",
       "      <td>Clinical - Medical, Prescription Drugs</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-04-24</th>\n",
       "      <th>(CDRH) ,Office of Product Evaluation and Quality</th>\n",
       "      <td>Enforcement Policy for Remote Digital Pathology Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry, Clinical Laboratories, Healthcare Facilities, Pathologists, and Food and Drug Administration Staff</td>\n",
       "      <td>Premarket, Radiology</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"2\" valign=\"top\">2020-04-23</th>\n",
       "      <th>(CDRH) ,Office of Product Evaluation and Quality</th>\n",
       "      <td>Enforcement Policy for Imaging Systems During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff</td>\n",
       "      <td>Premarket, Labeling, Radiology</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>(CDRH) ,Office of Product Evaluation and Quality</th>\n",
       "      <td>Enforcement Policy for Non-Invasive Fetal and Maternal Monitoring Devices Used to Support Patient Monitoring During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff</td>\n",
       "      <td>Premarket, Labeling</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"2\" valign=\"top\">2020-04-22</th>\n",
       "      <th>(CFSAN) (CVM) (ORA)</th>\n",
       "      <td>Temporary Policy Regarding Accredited Third-Party Certification Program Onsite Observation and Certificate Duration Requirements During the COVID-19 Public Health Emergency:  Guidance for Industry</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>(CDER)</th>\n",
       "      <td>Temporary Policy on Repackaging or Combining Propofol Drug Products During the COVID-19 Public Health Emergency:  Guidance for Industry</td>\n",
       "      <td>Compliance, Pharmaceutical Quality</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-04-20</th>\n",
       "      <th>(CDER)</th>\n",
       "      <td>Temporary Policy for Compounding of Certain Drugs for Hospitalized Patients by Pharmacy Compounders not Registered as Outsourcing Facilities During the COVID-19 Public Health Emergency Guidance for Industry:  Guidance for Industry</td>\n",
       "      <td>Compliance, Compounding</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"2\" valign=\"top\">2020-04-16</th>\n",
       "      <th>(CDRH) ,Office of Product Evaluation and Quality</th>\n",
       "      <td>Enforcement Policy for Telethermographic Systems During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff</td>\n",
       "      <td>Premarket, Postmarket, Labeling, Radiology</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>(CDER)</th>\n",
       "      <td>Temporary Policy for Compounding of Certain Drugs for Hospitalized Patients by Outsourcing Facilities During the COVID-19 Public Health Emergency</td>\n",
       "      <td>Compounding</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-04-14</th>\n",
       "      <th>(CDRH) (CDRH) ,Office of Product Evaluation and Quality</th>\n",
       "      <td>Enforcement Policy for Digital Health Devices For Treating Psychiatric Disorders During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff</td>\n",
       "      <td>Postmarket, Digital Health, Labeling, Premarket Approval (PMA)</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-04-10</th>\n",
       "      <th>(CDER)</th>\n",
       "      <td>Temporary Policy Regarding Non-Standard PPE Practices for Sterile Compounding by Pharmacy Compounders not Registered as Outsourcing Facilities During the COVID-19 Public Health Emergency:  Guidance for Industry</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-04-09</th>\n",
       "      <th>(CDER)</th>\n",
       "      <td>Policy for the Temporary Use of Portable Cryogenic Containers Not in Compliance With 21 CFR 211.94(e)(1) For Oxygen and Nitrogen During the COVID-19 Public Health Emergency Guidance for Industry:  Guidance for Industry</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"3\" valign=\"top\">2020-04-06</th>\n",
       "      <th>(CFSAN) ,Office of Food Safety</th>\n",
       "      <td>Temporary Policy Regarding Enforcement of 21 CFR Part 118 (the Egg Safety Rule) During the COVID-19 Public Health Emergency:  Guidance for Industry</td>\n",
       "      <td>Egg/Egg Product</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>(CDRH) ,Office of Product Evaluation and Quality</th>\n",
       "      <td>Enforcement Policy for Extracorporeal Membrane Oxygenation and Cardiopulmonary Bypass Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff</td>\n",
       "      <td>Cardiovascular</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>(CDRH) ,Office of Product Evaluation and Quality</th>\n",
       "      <td>Enforcement Policy for Remote Ophthalmic Assessment and Monitoring Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff</td>\n",
       "      <td>Ophthalmic</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-04-05</th>\n",
       "      <th>(CDRH)</th>\n",
       "      <td>Enforcement Policy for Infusion Pumps and Accessories During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and FDA Staff</td>\n",
       "      <td>Premarket, Postmarket, Device &amp; Drug Safety</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-04-04</th>\n",
       "      <th>(CDRH)</th>\n",
       "      <td>Enforcement Policy for Clinical Electronic Thermometers During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff</td>\n",
       "      <td>Premarket, Postmarket, Device &amp; Drug Safety</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"2\" valign=\"top\">2020-04-03</th>\n",
       "      <th>(CVM)</th>\n",
       "      <td>CVM GFI #270 - Guidance on the Conduct and Review of Studies to Support New Animal Drug Development during the COVID-19 Public Health Emergency</td>\n",
       "      <td>Premarket, Human Food Safety, Investigational New Animal Drug (INAD), New Animal Drug Application (NADA), Target Animal – Effectiveness</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>(CFSAN) ,Office of Nutrition and Food Labeling</th>\n",
       "      <td>Temporary Policy Regarding Packaging and Labeling of Shell Eggs Sold by Retail Food Establishments During the COVID-19 Public Health Emergency:  Guidance for Industry</td>\n",
       "      <td>Egg/Egg Product, Labeling, Packaging</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-04-02</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>Alternative Procedures for Blood and Blood Components During the COVID-19 Public Health Emergency:  Guidance for Industry</td>\n",
       "      <td>Public Awareness, Blood Products</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-04-01</th>\n",
       "      <th>(CFSAN) ,Office of Nutrition and Food Labeling</th>\n",
       "      <td>Temporary Policy Regarding Nutrition Labeling of Standard Menu Items in Chain Restaurants and Similar Retail Food Establishments During the COVID-19 Public Health Emergency:  Guidance for Industry</td>\n",
       "      <td>Labeling, Nutrition</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-03-30</th>\n",
       "      <th>(CDRH)</th>\n",
       "      <td>Enforcement Policy for Gowns, Other Apparel, and Gloves During the Coronavirus Disease (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-03-29</th>\n",
       "      <th>(CDRH)</th>\n",
       "      <td>Enforcement Policy for Sterilizers, Disinfectant Devices, and Air Purifiers During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff</td>\n",
       "      <td>Premarket, Labeling</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-03-26</th>\n",
       "      <th>(CFSAN) ,Office of Nutrition and Food Labeling</th>\n",
       "      <td>Temporary Policy Regarding Nutrition Labeling of Certain Packaged Food During the COVID-19 Public Health Emergency :  Guidance for Industry</td>\n",
       "      <td>Labeling</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-03-24</th>\n",
       "      <th>(CVM)</th>\n",
       "      <td>CVM GFI #269 - Enforcement Policy Regarding Federal VCPR Requirements to Facilitate Veterinary Telemedicine During the COVID-19 Outbreak</td>\n",
       "      <td>Animal Drugs, Veterinary Feed Directive</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"2\" valign=\"top\">2020-03-22</th>\n",
       "      <th>(CDRH)</th>\n",
       "      <td>Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff</td>\n",
       "      <td>510(k)</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>(CBER) (CDER)</th>\n",
       "      <td>Policy for Certain REMS Requirements During the COVID-19 Public Health Emergency Guidance for Industry and Health Care Professionals</td>\n",
       "      <td>Clinical - Medical</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                                                                                                                                                                                                                                             Summary  \\\n",
       "Issue Date0 FDA Organization                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "2022-05-04  (CBER) (CDRH)                                                                                                                                                                       Supplements for Approved Premarket Approval (PMA) or Humanitarian Device Exemption (HDE) Submissions During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised):  Guidance for Industry and Food and Drug Administration Staff   \n",
       "2022-03-31  (CBER)                                                                                                                                                                                                                                                                                                                                              Emergency Use Authorization for Vaccines to Prevent COVID-19:  Guidance for Industry   \n",
       "2022-02-08  (CDER)                                                                                                                                                                                                                                                                                                          COVID-19 Public Health Emergency Policy on COVID-19-Related Sanitation Tunnels:  Guidance for Industry and Investigators   \n",
       "2022-02-04  (OCE) (CBER) (CDER)                                                                                                                                                                                                                                                                             Nonclinical Considerations for Mitigating Nonhuman Primate Supply Constraints Arising from the COVID-19 Pandemic:  Guidance for Industry   \n",
       "2022-01-07  (CBER)                                                                                                                                                                                                                                                                                                                                                              Investigational COVID-19 Convalescent Plasma:  Guidance for Industry   \n",
       "2021-12-23  (CDRH)                                                                                                                                                                                                         Transition Plan for Medical Devices Issued Emergency Use Authorizations (EUAs) During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency: Draft Guidance for Industry and Food and Drug Administration Staff   \n",
       "            (CDRH)                                                                                                                                                                                                       Transition Plan for Medical Devices That Fall Within Enforcement Policies Issued During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency: Draft Guidance for Industry and Food and Drug Administration Staff   \n",
       "2021-12-10  (CBER)                                                                                                                                                                                                                                                        Policy for Certain REMS Requirements During the Tocilizumab Shortage Related to the COVID-19 Public Health Emergency:  Guidance for Industry and Health Care Professionals   \n",
       "2021-11-15  (CDRH)                                                                                                                                                                                              Enforcement Policy for Viral Transport Media During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised):  Guidance for Commercial Manufacturers, Clinical Laboratories, and Food and Drug Administration Staff   \n",
       "2021-09-15  (CDRH)                                                                                                                                                                               Enforcement Policy for Face Masks, Barrier Face Coverings, Face Shields, Surgical Masks, and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Revised):  Guidance for Industry and Food and Drug Administration Staff   \n",
       "2021-09-08  (CDER)                                                                                                                                                                                                                                                                                Development of Abbreviated New  Drug Applications During the  COVID-19 Pandemic – Questions and  Answers Guidance for Industry:  COVID 19 Guidance   \n",
       "2021-08-30  (CBER) (CDRH) (CDER) Office of the Commissioner,Office of Clinical Policy and Programs,Office of Clinical Policy,Office of Good Clinical Practice                                                                                                     FDA Guidance on Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency:  Guidance for Industry, Investigators, and Institutional Review Boards   \n",
       "2021-05-17  (ORA) (CBER) (CDER)                                                                                                                                                                                                                                                       Manufacturing, Supply Chain, and Drug and Biological Product Inspections During COVID-19 Public Health Emergency Questions and Answers:  Guidance for Industry   \n",
       "            (OCE) (CBER) (CDER)                                                                                                                                                                                                                                                                                              COVID-19: Master Protocols Evaluating Drugs and Biological Products for Treatment or Prevention:  Guidance for Industry   \n",
       "2021-04-14  (CVM) (CBER) (CDER)                                                                                                                                                                                                                                Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities During the COVID-19 Public Health Emergency  Guidance for Industry:  Guidance for Industry   \n",
       "2021-03-04  (CBER) (CDER)                                                                                                                                                                                                                                                                                           COVID-19 Container Closure System and Component Changes: Glass Vials and Stoppers  Guidance for Industry:  Guidance for Industry   \n",
       "2021-02-22  (CDRH)                                                                                                                                                                                                                                                                                           Policy for Evaluating Impact of Viral Mutations on COVID-19 Tests:  Guidance for Test Developers and Food and Drug Administration Staff   \n",
       "            (CDER)                                                                                                                                                                                                                                                               Development of Monoclonal Antibody Products Targeting SARS-CoV-2, Including Addressing the Impact of Emerging Variants, During the COVID 19 Public Health Emergency   \n",
       "2021-01-28  (CDRH)                                                                                                                                                                                                Coagulation Systems for Measurement of Viscoelastic Properties: Enforcement Policy During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised):  Guidance for Industry and Food and Drug Administration Staff   \n",
       "2021-01-19  (CDER) (CBER) (CVM)                                                                                                                                                                                                                                                         Policy for Testing of Alcohol (Ethanol) and Isopropyl Alcohol for Methanol, Including During the Public Health Emergency  (COVID-19):  Guidance for Industry   \n",
       "            (CBER)                                                                                                                                                                                                                                                                  Manufacturing Considerations for Licensed and Investigational Cellular and Gene Therapy Products During COVID-19 Public Health Emergency:  Guidance for Industry   \n",
       "2021-01-15  (CDER)                                                                                                                                                                                                                                                                                               Protecting Participants in Bioequivalence Studies for Abbreviated New Drug Applications During the COVID-19 Public Health Emergency   \n",
       "2021-01-13  (CDER)                                                                                                                                                                                                                                                                                                  COVID-19: Potency Assay Considerations for Monoclonal Antibodies and Other Therapeutic Proteins Targeting SARS-CoV-2 Infectivity   \n",
       "2020-12-21  (CBER) (CDER)                                                                                                                                                                                                                       Review Timelines for Applicant Responses to Complete Response Letters When a Facility Assessment Is Needed During the COVID-19 Public Health Emergency Guidance for Industry:  Guidance for Industry   \n",
       "2020-12-04  (CDRH)                                                                                                                                             Enforcement Policy for the Quality Standards of the Mammography Quality Standards Act During the COVID-19 Public Health Emergency:  Guidance for Mammography Facilities, State MQSA Contract Partners, FDA-Approved MQSA Accreditation Bodies, and Food and Drug Administration Staff   \n",
       "2020-11-25  (CDRH) ,Office of Strategic Partnerships and Technology Innovation                                                                                                                     Notifying CDRH of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act During the COVID-19 Public Health Emergency (Revised):  Guidance for Industry and Food and Drug Administration Staff   \n",
       "2020-10-28  (CDRH)                                                                                                                                                                                  Enforcement Policy for Non-Invasive Remote Monitoring Devices Used to Support Patient Monitoring During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised):  Guidance for Industry and Food and Drug Administration Staff   \n",
       "2020-10-13  (CDRH) ,Office of Product Evaluation and Quality                                                                                                                                                             Enforcement Policy for Modifications to FDA Cleared Molecular Influenza and RSV Tests During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff   \n",
       "2020-09-14  (CBER) (CDER)                                                                                                                                                                                                                          Assessing COVID-19-Related Symptoms in Outpatient Adult and Adolescent Subjects in Clinical Trials of Drugs and Biological Products for COVID-19 Prevention or Treatment :  Guidance for Industry   \n",
       "2020-09-10  (CVM) (CBER) (CDER)                                                                                                                                                                                                                                                                                      Resuming Normal Drug and Biologics Manufacturing Operations During the COVID-19 Public Health Emergency:  Guidance for Industry   \n",
       "2020-06-30  (CBER)                                                                                                                                                                                                                                                                                                                                                 Development and Licensure of Vaccines to Prevent COVID-19:  Guidance for Industry   \n",
       "2020-06-19  (CVM) (CBER) (CDER)                                                                                                                                                                                                                                                   Good Manufacturing Practice Considerations for Responding to COVID-19 Infection in Employees in Drug and Biological Products Manufacturing:  Guidance for Industry   \n",
       "2020-06-16  (CDER) (CBER) (CDRH) (CVM)                                                                                                                                                                                                                                                                      Statistical Considerations for Clinical Trials During the COVID-19 Public Health Emergency Guidance for Industry:  Guidance for Industry   \n",
       "2020-06-08  (CDER)                                                                                                                                                                                                                                                             Temporary Policy on Prescription Drug Marketing Act Requirements for Distribution of Drug Samples During the COVID-19 Public Health Emergency:  Guidance for Industry   \n",
       "2020-06-04  (CFSAN) (CVM)                                                                                                                                                                                                                                           Temporary Policy Regarding Preventive Controls and FSVP Food Supplier Verification Onsite Audit Requirements During the COVID-19 Public Health Emergency:  Guidance for Industry   \n",
       "2020-06-02  (CDER)                                                                                                                                               Institutional Review Board (IRB) Review of Individual Patient Expanded Access Requests for Investigational Drugs and Biological Products During the COVID-19 Public Health Emergency   Guidance for IRBs and Clinical Investigators:   Guidance for IRBs and Clinical Investigators   \n",
       "2020-05-27  (CFSAN)                                                                                                                                                                                                                                Reporting a Temporary Closure or Significantly Reduced Production by a Human Food Establishment and Requesting FDA Assistance During the COVID-19 Public Health Emergency:  Guidance for Industry   \n",
       "2020-05-26  (CDER) (CBER)                                                                                                                                                                                                                                                                                                       Effects of the COVID-19 Public Health Emergency on Formal Meetings and User Fee Applications — Questions and Answers   \n",
       "2020-05-22  (CFSAN) ,Office of Nutrition and Food Labeling                                                                                                                                                                                                         Temporary Policy Regarding Certain Food Labeling Requirements During the COVID-19 Public Health Emergency: Minor Formulation Changes and Vending Machines:  Guidance for Industry   \n",
       "            (CFSAN)                                                                                                                                                                                                     Temporary Policy During the COVID-19 Public Health Emergency Regarding the Qualified Exemption from the Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption:  Guidance for Industry   \n",
       "2020-05-12  (CVM) (CFSAN)                                                                                                                                                                                                                                      Returning Refrigerated Transport Vehicles and Refrigerated Storage Units to Food Uses After Using Them to Preserve Human Remains During the COVID-19 Pandemic:  Guidance for Industry   \n",
       "2020-05-11  (CDER) (CBER)                                                                                                                                                                                                                                       COVID-19 Public Health Emergency: General Considerations for Pre-IND  Meeting Requests for COVID-19 Related Drugs and Biological Products :  Guidance for Industry and Investigators   \n",
       "            (CBER) (CDER)                                                                                                                                                                                                                                                                                                                     COVID-19: Developing Drugs and Biological Products for Treatment or Prevention:  Guidance for Industry   \n",
       "2020-05-07  (CVM)                                                                                                                                                                                                                                                                                                                            CVM GFI #271 Reporting and Mitigating Animal Drug Shortages during the COVID-19 Public Health Emergency   \n",
       "2020-04-30  (CDER) (CBER)                                                                                                                                                                                                                                                                Exemption and Exclusion from Certain Requirements of the Drug Supply Chain Security Act During the COVID-19 Public Health Emergency:  Guidance for Industry   \n",
       "2020-04-24  (CDRH) ,Office of Product Evaluation and Quality                                                                                                                              Enforcement Policy for Remote Digital Pathology Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry, Clinical Laboratories, Healthcare Facilities, Pathologists, and Food and Drug Administration Staff   \n",
       "2020-04-23  (CDRH) ,Office of Product Evaluation and Quality                                                                                                                                                                                                            Enforcement Policy for Imaging Systems During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff   \n",
       "            (CDRH) ,Office of Product Evaluation and Quality                                                                                                                                      Enforcement Policy for Non-Invasive Fetal and Maternal Monitoring Devices Used to Support Patient Monitoring During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff   \n",
       "2020-04-22  (CFSAN) (CVM) (ORA)                                                                                                                                                                                                                 Temporary Policy Regarding Accredited Third-Party Certification Program Onsite Observation and Certificate Duration Requirements During the COVID-19 Public Health Emergency:  Guidance for Industry   \n",
       "            (CDER)                                                                                                                                                                                                                                                                                           Temporary Policy on Repackaging or Combining Propofol Drug Products During the COVID-19 Public Health Emergency:  Guidance for Industry   \n",
       "2020-04-20  (CDER)                                                                                                                                                                                            Temporary Policy for Compounding of Certain Drugs for Hospitalized Patients by Pharmacy Compounders not Registered as Outsourcing Facilities During the COVID-19 Public Health Emergency Guidance for Industry:  Guidance for Industry   \n",
       "2020-04-16  (CDRH) ,Office of Product Evaluation and Quality                                                                                                                                                                                                  Enforcement Policy for Telethermographic Systems During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff   \n",
       "            (CDER)                                                                                                                                                                                                                                                                                 Temporary Policy for Compounding of Certain Drugs for Hospitalized Patients by Outsourcing Facilities During the COVID-19 Public Health Emergency   \n",
       "2020-04-14  (CDRH) (CDRH) ,Office of Product Evaluation and Quality                                                                                                                                                           Enforcement Policy for Digital Health Devices For Treating Psychiatric Disorders During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff   \n",
       "2020-04-10  (CDER)                                                                                                                                                                                                                Temporary Policy Regarding Non-Standard PPE Practices for Sterile Compounding by Pharmacy Compounders not Registered as Outsourcing Facilities During the COVID-19 Public Health Emergency:  Guidance for Industry   \n",
       "2020-04-09  (CDER)                                                                                                                                                                                                        Policy for the Temporary Use of Portable Cryogenic Containers Not in Compliance With 21 CFR 211.94(e)(1) For Oxygen and Nitrogen During the COVID-19 Public Health Emergency Guidance for Industry:  Guidance for Industry   \n",
       "2020-04-06  (CFSAN) ,Office of Food Safety                                                                                                                                                                                                                                                       Temporary Policy Regarding Enforcement of 21 CFR Part 118 (the Egg Safety Rule) During the COVID-19 Public Health Emergency:  Guidance for Industry   \n",
       "            (CDRH) ,Office of Product Evaluation and Quality                                                                                                                                                     Enforcement Policy for Extracorporeal Membrane Oxygenation and Cardiopulmonary Bypass Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff   \n",
       "            (CDRH) ,Office of Product Evaluation and Quality                                                                                                                                                                        Enforcement Policy for Remote Ophthalmic Assessment and Monitoring Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff   \n",
       "2020-04-05  (CDRH)                                                                                                                                                                                                                                                                Enforcement Policy for Infusion Pumps and Accessories During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and FDA Staff   \n",
       "2020-04-04  (CDRH)                                                                                                                                                                                                                                     Enforcement Policy for Clinical Electronic Thermometers During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff   \n",
       "2020-04-03  (CVM)                                                                                                                                                                                                                                                                                    CVM GFI #270 - Guidance on the Conduct and Review of Studies to Support New Animal Drug Development during the COVID-19 Public Health Emergency   \n",
       "            (CFSAN) ,Office of Nutrition and Food Labeling                                                                                                                                                                                                                    Temporary Policy Regarding Packaging and Labeling of Shell Eggs Sold by Retail Food Establishments During the COVID-19 Public Health Emergency:  Guidance for Industry   \n",
       "2020-04-02  (CBER)                                                                                                                                                                                                                                                                                                         Alternative Procedures for Blood and Blood Components During the COVID-19 Public Health Emergency:  Guidance for Industry   \n",
       "2020-04-01  (CFSAN) ,Office of Nutrition and Food Labeling                                                                                                                                                                                      Temporary Policy Regarding Nutrition Labeling of Standard Menu Items in Chain Restaurants and Similar Retail Food Establishments During the COVID-19 Public Health Emergency:  Guidance for Industry   \n",
       "2020-03-30  (CDRH)                                                                                                                                                                                                                                          Enforcement Policy for Gowns, Other Apparel, and Gloves During the Coronavirus Disease (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff   \n",
       "2020-03-29  (CDRH)                                                                                                                                                                                                                 Enforcement Policy for Sterilizers, Disinfectant Devices, and Air Purifiers During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff   \n",
       "2020-03-26  (CFSAN) ,Office of Nutrition and Food Labeling                                                                                                                                                                                                                                               Temporary Policy Regarding Nutrition Labeling of Certain Packaged Food During the COVID-19 Public Health Emergency :  Guidance for Industry   \n",
       "2020-03-24  (CVM)                                                                                                                                                                                                                                                                                           CVM GFI #269 - Enforcement Policy Regarding Federal VCPR Requirements to Facilitate Veterinary Telemedicine During the COVID-19 Outbreak   \n",
       "2020-03-22  (CDRH)                                                                                                                                                                                                            Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency:  Guidance for Industry and Food and Drug Administration Staff   \n",
       "            (CBER) (CDER)                                                                                                                                                                                                                                                                                       Policy for Certain REMS Requirements During the COVID-19 Public Health Emergency Guidance for Industry and Health Care Professionals   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                 Topic  \\\n",
       "Issue Date0 FDA Organization                                                                                                                                                                                                                                                                             \n",
       "2022-05-04  (CBER) (CDRH)                                                                                                                                                                                                                                            HUD/HDE, Premarket Approval (PMA)   \n",
       "2022-03-31  (CBER)                                                                                                                                                                                                                                                                            Vaccines   \n",
       "2022-02-08  (CDER)                                                                                                                                                                                                                                                                                 NaN   \n",
       "2022-02-04  (OCE) (CBER) (CDER)                                                                                                                                                                                                                                                Pharmacology/Toxicology   \n",
       "2022-01-07  (CBER)                                                                                                                                                                                                                                                                      Blood Products   \n",
       "2021-12-23  (CDRH)                                                                                                                                                                                                                                                              Premarket, Postmarket,   \n",
       "            (CDRH)                                                                                                                                                                                                                                                              Premarket, Postmarket,   \n",
       "2021-12-10  (CBER)                                                                                                                                                                                                                                                                        Gene Therapy   \n",
       "2021-11-15  (CDRH)                                                                                                                                                                                                                                                                   Premarket, 510(k)   \n",
       "2021-09-15  (CDRH)                                                                                                                                                                                                                                                                 Premarket, Labeling   \n",
       "2021-09-08  (CDER)                                                                                                                                                                                                                                                                                 NaN   \n",
       "2021-08-30  (CBER) (CDRH) (CDER) Office of the Commissioner,Office of Clinical Policy and Programs,Office of Clinical Policy,Office of Good Clinical Practice                                                                                                          Emergencies, Clinical - Medical   \n",
       "2021-05-17  (ORA) (CBER) (CDER)                                                                                                                                                                                                                                                                    NaN   \n",
       "            (OCE) (CBER) (CDER)                                                                                                                                                                                                                                                                    NaN   \n",
       "2021-04-14  (CVM) (CBER) (CDER)                                                                                                                                                                                                                                                                    NaN   \n",
       "2021-03-04  (CBER) (CDER)                                                                                                                                                                                                                                                                          NaN   \n",
       "2021-02-22  (CDRH)                                                                                                                                                                                                                                       Premarket, IVDs (In Vitro Diagnostic Devices)   \n",
       "            (CDER)                                                                                                                                                                                                                                                                                 NaN   \n",
       "2021-01-28  (CDRH)                                                                                                                                                                                                                       Premarket, Hematology & Pathology , Immunology & Microbiology   \n",
       "2021-01-19  (CDER) (CBER) (CVM)                                                                                                                                                                                                                                                                    NaN   \n",
       "            (CBER)                                                                                                                                                                                                                                                                        Gene Therapy   \n",
       "2021-01-15  (CDER)                                                                                                                                                                                                                                                                      Bioequivalence   \n",
       "2021-01-13  (CDER)                                                                                                                                                                                                                                                                                 NaN   \n",
       "2020-12-21  (CBER) (CDER)                                                                                                                                                                                                                                                                          NaN   \n",
       "2020-12-04  (CDRH)                                                                                                                                                                                                                                                      Radiological Health, Radiology   \n",
       "2020-11-25  (CDRH) ,Office of Strategic Partnerships and Technology Innovation                                                                                                                                                                                                             Postmarket,   \n",
       "2020-10-28  (CDRH)                                                                                                                                                                                                                                                         Premarket, 510(k), Labeling   \n",
       "2020-10-13  (CDRH) ,Office of Product Evaluation and Quality                                                                                                                                                                                                        IVDs (In Vitro Diagnostic Devices)   \n",
       "2020-09-14  (CBER) (CDER)                                                                                                                                                                                                                                                           Clinical - Medical   \n",
       "2020-09-10  (CVM) (CBER) (CDER)                                                                                                                                                                                                                                                                    NaN   \n",
       "2020-06-30  (CBER)                                                                                                                                                                                                                                                                            Vaccines   \n",
       "2020-06-19  (CVM) (CBER) (CDER)                                                                                                                                                                                                                                                                    NaN   \n",
       "2020-06-16  (CDER) (CBER) (CDRH) (CVM)                                                                                                                                                                                                                                                Clinical Trials,   \n",
       "2020-06-08  (CDER)                                                                                                                                                                                                                                              Clinical - Medical, Prescription Drugs   \n",
       "2020-06-04  (CFSAN) (CVM)                                                                                                                                                                                                                                                                          NaN   \n",
       "2020-06-02  (CDER)                                                                                                                                                                                                                                                                                 NaN   \n",
       "2020-05-27  (CFSAN)                                                                                                                                                                                                                                                                                NaN   \n",
       "2020-05-26  (CDER) (CBER)                                                                                                                                                                                                                                                                          NaN   \n",
       "2020-05-22  (CFSAN) ,Office of Nutrition and Food Labeling                                                                                                                                                                                                                                    Labeling   \n",
       "            (CFSAN)                                                                                                                                                                                                                                                                                NaN   \n",
       "2020-05-12  (CVM) (CFSAN)                                                                                                                                                                                                                                                               Transportation   \n",
       "2020-05-11  (CDER) (CBER)                                                                                                                                                                                                                                                                          NaN   \n",
       "            (CBER) (CDER)                                                                                                                                                                                                                                                           Clinical - Medical   \n",
       "2020-05-07  (CVM)                                                                                                                                                                                                               Postmarket, Animal Drugs, Chemistry, Manufacturing, and Controls (CMC)   \n",
       "2020-04-30  (CDER) (CBER)                                                                                                                                                                                                                                       Clinical - Medical, Prescription Drugs   \n",
       "2020-04-24  (CDRH) ,Office of Product Evaluation and Quality                                                                                                                                                                                                                      Premarket, Radiology   \n",
       "2020-04-23  (CDRH) ,Office of Product Evaluation and Quality                                                                                                                                                                                                            Premarket, Labeling, Radiology   \n",
       "            (CDRH) ,Office of Product Evaluation and Quality                                                                                                                                                                                                                       Premarket, Labeling   \n",
       "2020-04-22  (CFSAN) (CVM) (ORA)                                                                                                                                                                                                                                                                    NaN   \n",
       "            (CDER)                                                                                                                                                                                                                                                  Compliance, Pharmaceutical Quality   \n",
       "2020-04-20  (CDER)                                                                                                                                                                                                                                                             Compliance, Compounding   \n",
       "2020-04-16  (CDRH) ,Office of Product Evaluation and Quality                                                                                                                                                                                                Premarket, Postmarket, Labeling, Radiology   \n",
       "            (CDER)                                                                                                                                                                                                                                                                         Compounding   \n",
       "2020-04-14  (CDRH) (CDRH) ,Office of Product Evaluation and Quality                                                                                                                                                                     Postmarket, Digital Health, Labeling, Premarket Approval (PMA)   \n",
       "2020-04-10  (CDER)                                                                                                                                                                                                                                                                                 NaN   \n",
       "2020-04-09  (CDER)                                                                                                                                                                                                                                                                                 NaN   \n",
       "2020-04-06  (CFSAN) ,Office of Food Safety                                                                                                                                                                                                                                             Egg/Egg Product   \n",
       "            (CDRH) ,Office of Product Evaluation and Quality                                                                                                                                                                                                                            Cardiovascular   \n",
       "            (CDRH) ,Office of Product Evaluation and Quality                                                                                                                                                                                                                                Ophthalmic   \n",
       "2020-04-05  (CDRH)                                                                                                                                                                                                                                         Premarket, Postmarket, Device & Drug Safety   \n",
       "2020-04-04  (CDRH)                                                                                                                                                                                                                                         Premarket, Postmarket, Device & Drug Safety   \n",
       "2020-04-03  (CVM)                                                                                                                                              Premarket, Human Food Safety, Investigational New Animal Drug (INAD), New Animal Drug Application (NADA), Target Animal – Effectiveness   \n",
       "            (CFSAN) ,Office of Nutrition and Food Labeling                                                                                                                                                                                                        Egg/Egg Product, Labeling, Packaging   \n",
       "2020-04-02  (CBER)                                                                                                                                                                                                                                                    Public Awareness, Blood Products   \n",
       "2020-04-01  (CFSAN) ,Office of Nutrition and Food Labeling                                                                                                                                                                                                                         Labeling, Nutrition   \n",
       "2020-03-30  (CDRH)                                                                                                                                                                                                                                                                                 NaN   \n",
       "2020-03-29  (CDRH)                                                                                                                                                                                                                                                                 Premarket, Labeling   \n",
       "2020-03-26  (CFSAN) ,Office of Nutrition and Food Labeling                                                                                                                                                                                                                                    Labeling   \n",
       "2020-03-24  (CVM)                                                                                                                                                                                                                                              Animal Drugs, Veterinary Feed Directive   \n",
       "2020-03-22  (CDRH)                                                                                                                                                                                                                                                                              510(k)   \n",
       "            (CBER) (CDER)                                                                                                                                                                                                                                                           Clinical - Medical   \n",
       "\n",
       "                                                                                                                                                              Guidance Status  \n",
       "Issue Date0 FDA Organization                                                                                                                                                   \n",
       "2022-05-04  (CBER) (CDRH)                                                                                                                                               Final  \n",
       "2022-03-31  (CBER)                                                                                                                                                      Final  \n",
       "2022-02-08  (CDER)                                                                                                                                                      Final  \n",
       "2022-02-04  (OCE) (CBER) (CDER)                                                                                                                                         Final  \n",
       "2022-01-07  (CBER)                                                                                                                                                      Final  \n",
       "2021-12-23  (CDRH)                                                                                                                                                      Draft  \n",
       "            (CDRH)                                                                                                                                                      Draft  \n",
       "2021-12-10  (CBER)                                                                                                                                                      Final  \n",
       "2021-11-15  (CDRH)                                                                                                                                                      Final  \n",
       "2021-09-15  (CDRH)                                                                                                                                                      Final  \n",
       "2021-09-08  (CDER)                                                                                                                                                      Final  \n",
       "2021-08-30  (CBER) (CDRH) (CDER) Office of the Commissioner,Office of Clinical Policy and Programs,Office of Clinical Policy,Office of Good Clinical Practice           Final  \n",
       "2021-05-17  (ORA) (CBER) (CDER)                                                                                                                                         Final  \n",
       "            (OCE) (CBER) (CDER)                                                                                                                                         Final  \n",
       "2021-04-14  (CVM) (CBER) (CDER)                                                                                                                                         Final  \n",
       "2021-03-04  (CBER) (CDER)                                                                                                                                               Final  \n",
       "2021-02-22  (CDRH)                                                                                                                                                      Final  \n",
       "            (CDER)                                                                                                                                                      Final  \n",
       "2021-01-28  (CDRH)                                                                                                                                                      Final  \n",
       "2021-01-19  (CDER) (CBER) (CVM)                                                                                                                                         Final  \n",
       "            (CBER)                                                                                                                                                      Final  \n",
       "2021-01-15  (CDER)                                                                                                                                                      Final  \n",
       "2021-01-13  (CDER)                                                                                                                                                      Final  \n",
       "2020-12-21  (CBER) (CDER)                                                                                                                                               Final  \n",
       "2020-12-04  (CDRH)                                                                                                                                                      Final  \n",
       "2020-11-25  (CDRH) ,Office of Strategic Partnerships and Technology Innovation                                                                                          Final  \n",
       "2020-10-28  (CDRH)                                                                                                                                                      Final  \n",
       "2020-10-13  (CDRH) ,Office of Product Evaluation and Quality                                                                                                            Final  \n",
       "2020-09-14  (CBER) (CDER)                                                                                                                                               Final  \n",
       "2020-09-10  (CVM) (CBER) (CDER)                                                                                                                                         Final  \n",
       "2020-06-30  (CBER)                                                                                                                                                      Final  \n",
       "2020-06-19  (CVM) (CBER) (CDER)                                                                                                                                         Final  \n",
       "2020-06-16  (CDER) (CBER) (CDRH) (CVM)                                                                                                                                  Final  \n",
       "2020-06-08  (CDER)                                                                                                                                                      Final  \n",
       "2020-06-04  (CFSAN) (CVM)                                                                                                                                               Final  \n",
       "2020-06-02  (CDER)                                                                                                                                                      Final  \n",
       "2020-05-27  (CFSAN)                                                                                                                                                     Final  \n",
       "2020-05-26  (CDER) (CBER)                                                                                                                                               Final  \n",
       "2020-05-22  (CFSAN) ,Office of Nutrition and Food Labeling                                                                                                              Final  \n",
       "            (CFSAN)                                                                                                                                                     Final  \n",
       "2020-05-12  (CVM) (CFSAN)                                                                                                                                               Final  \n",
       "2020-05-11  (CDER) (CBER)                                                                                                                                               Final  \n",
       "            (CBER) (CDER)                                                                                                                                               Final  \n",
       "2020-05-07  (CVM)                                                                                                                                                       Final  \n",
       "2020-04-30  (CDER) (CBER)                                                                                                                                               Final  \n",
       "2020-04-24  (CDRH) ,Office of Product Evaluation and Quality                                                                                                            Final  \n",
       "2020-04-23  (CDRH) ,Office of Product Evaluation and Quality                                                                                                            Final  \n",
       "            (CDRH) ,Office of Product Evaluation and Quality                                                                                                            Final  \n",
       "2020-04-22  (CFSAN) (CVM) (ORA)                                                                                                                                         Final  \n",
       "            (CDER)                                                                                                                                                      Final  \n",
       "2020-04-20  (CDER)                                                                                                                                                      Final  \n",
       "2020-04-16  (CDRH) ,Office of Product Evaluation and Quality                                                                                                            Final  \n",
       "            (CDER)                                                                                                                                                      Final  \n",
       "2020-04-14  (CDRH) (CDRH) ,Office of Product Evaluation and Quality                                                                                                     Final  \n",
       "2020-04-10  (CDER)                                                                                                                                                      Final  \n",
       "2020-04-09  (CDER)                                                                                                                                                      Final  \n",
       "2020-04-06  (CFSAN) ,Office of Food Safety                                                                                                                              Final  \n",
       "            (CDRH) ,Office of Product Evaluation and Quality                                                                                                            Final  \n",
       "            (CDRH) ,Office of Product Evaluation and Quality                                                                                                            Final  \n",
       "2020-04-05  (CDRH)                                                                                                                                                      Final  \n",
       "2020-04-04  (CDRH)                                                                                                                                                      Final  \n",
       "2020-04-03  (CVM)                                                                                                                                                       Final  \n",
       "            (CFSAN) ,Office of Nutrition and Food Labeling                                                                                                              Final  \n",
       "2020-04-02  (CBER)                                                                                                                                                      Final  \n",
       "2020-04-01  (CFSAN) ,Office of Nutrition and Food Labeling                                                                                                              Final  \n",
       "2020-03-30  (CDRH)                                                                                                                                                      Final  \n",
       "2020-03-29  (CDRH)                                                                                                                                                      Final  \n",
       "2020-03-26  (CFSAN) ,Office of Nutrition and Food Labeling                                                                                                              Final  \n",
       "2020-03-24  (CVM)                                                                                                                                                       Final  \n",
       "2020-03-22  (CDRH)                                                                                                                                                      Final  \n",
       "            (CBER) (CDER)                                                                                                                                               Final  "
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "lst2.set_index(['Issue Date0','FDA Organization']).sort_values(['Issue Date0','FDA Organization'],ascending=False).drop(['Open for Comment','Docket Number','Issue Date'], axis=1)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "P3_nbenv",
   "language": "python",
   "name": "nbenv"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
